Table 4.
Summary of Reporting of Adverse Events (AEs) and Dropouts (DOs) in Randomized Controlled Trials of Therapeutic Exercise for Hip Osteoarthritis (n = 14)
| Category | No. (%) | References |
|---|---|---|
| Total participants exercising | 707 | |
| Total exercise arms across all studies | 18 | |
| Studies with a clear statement of AEs | 6 (42.9) | 23 , 24 , 27 , 29 , 33 , 34 |
| Participants in studies that had a clear statement of AEsa | 344 (48.7) | |
| AEs reportedb | 32 (4.5) | 23 , 29 |
| Studies with a clear statement of DOs | 14 (100.0) | 22–35 |
| Studies that reported DOsb | 13 (92.9) | 22–35 |
| DOs reportedb | 69 (9.8) | |
| Studies that reported DOs without clear reasons | 8 (57.1) | 22 , 23 , 26 , 27 , 30 , 33 , 35 |
| DOs reported with unclear reasons | 20 (29.0) | |
| Studies where reasons for DOs could be AEs (eg, increased pain) | 6 (42.9) | 26 , 28 , 30 , 31 , 34 , 35 |
| DOs with reasons that could be AEs | 9 (13.0) | |
| Participants who dropped out where reason could be considered an AEb | 9 (1.3) | |
| Participants who dropped out where reason could be considered an AE plus total number of AEs reportedb | 41 (5.8) |
a All AEs were related to the therapeutic exercise intervention.
b Among all participants allocated to the exercise intervention.